NCT06390098

Positron Emission Tomography Study in Healthy Subjects to Determine the Relationship Between Plasma Concentration and Brain Target Occupancy of ASN51

A Phase 1, Open-Label, Positron Emission Tomography Study in Healthy Adult Subjects to Determine the Relationship Between Plasma Concentration and Brain Target Occupancy of ASN51 Following a Single Oral Dose

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 3 (actual)
• Sponsor: Asceneuron S.A. · Industry
• Sex: All
• Age: 25 Years – 55 Years
• Healthy volunteers: Accepted

Summary

This is a phase 1, open-label, positron emission tomography (PET) study in healthy adult participants to determine the relationship between plasma concentration and brain target occupancy of ASN51 following a single oral dose.

Conditions

• Healthy Participants

Interventions

Type	Name	Description
DRUG	ASN51	Oral

Timeline

• Start date: 2021-08-09
• Primary completion: 2021-10-12
• Completion: 2021-10-12
• First posted: 2024-04-30
• Last updated: 2025-05-08
• Results posted: 2025-05-08

Locations

1 site across 1 country: United Kingdom